{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-036412","form_type":"8-K","ticker":"NATR","cik":"0000275053","company_name":"NATURES SUNSHINE PRODUCTS INC","filed_at":"2024-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.452382+00:00","generated_at":"2026-05-31T10:33:51.006524+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Nature's Sunshine Q2 net sales down 5% to $110.6M; cuts FY2024 guidance","bullets":["GAAP diluted EPS $0.07 vs $0.12 year ago; net income $1.3M down from $2.4M.","Adjusted EBITDA $10.4M, down 8% vs Q2 2023; gross margin fell 125 bps to 71.4%.","FY2024 net sales guidance lowered to $436-445M (prior $455-480M); EBITDA now $39-42M.","Asia segment down 8.9% on China headwinds; North America -3.2% due to temporary disruption.","Cash $68.7M, zero debt; $5M annualized SG&A reduction implemented."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-036412","json":"https://secwatch.observer/filing/0001628280-24-036412.json","markdown":"https://secwatch.observer/filing/0001628280-24-036412.md","text":"https://secwatch.observer/filing/0001628280-24-036412.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/275053/000162828024036412/0001628280-24-036412-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/275053/000162828024036412/natr-20240808.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:33:51.006524+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}